News

PharmiWeb25m
Global Plasmid DNA Manufacturing Market to Reach USD 10.67 Billion by 2033: Key Insights, Growth Drivers, and Challenges
IntroductionThe Global Plasmid DNA Manufacturing Market is poised for significant growth, with a valuation of USD 2.13 ...
The Manila Times27m
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, 'P134 Cell Injection,' which has received Investigational New Drug (IND) ...
Addgene Adds Science and Tech Leaders to Its Management Team and Board of Directors
Addgene is thrilled to have the expertise of this group of leaders in life sciences and technology as part of our management team and Board of Directors – a testament to the value of our vision for a ...
PharmiWeb1d
Viral Vector and Plasmid DNA Manufacturing Market: Trends, Opportunities, and Future Outlook
The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...
Taiwan News2d
Vietnam Viral Vector and Plasmid DNA Manufacturing Market Momentum Riding the Wave of Dazzling Latest Trends 2024-2032
Report Ocean’s latest analysis delves into the “Vietnam Viral Vector and Plasmid DNA Manufacturing Market” Report from 2024 to 2032, covering an array of market facets such as characteristics, size, ...